LCN2 and chronic kidney disease: Transcripts encoding AKI biomarkers including Kim-1 (Havcr1), Ngal (Lcn2), Spp1 (osteopontin) and Clu (clusterin) were increased across all AKI and CKD models (Figs 2 and 3, S1).